The Global Apheresis Market was valued at US$ 1,900 million in 2020, and it is expected to reach US$ 3,400 million by 2027, with a CAGR of 9.2%, during the forecast period, 2021 - 2027.
It is a clinical procedure in which all blood components can separate post removing the whole blood from a patient or individual or donor. In addition, after completion of separation procedure the remaining components are returned into main bloodstream. This procedure is referred by other terms such as hemapheresis or pheresis. These various terms indicate the component that is being removed. For instance, plateletpheresis indicates removal of platelets, the lymphapheresis or lymphopheresis indicates the removal of lymphocytes.
This medical procedure can be performed for complete blood composition exchange or replacement. For example, the complete plasma can be replaced with fresh plasma. Hence, this procedure has various key applications in the healthcare field. In addition, the apheresis is also used to collect the stem cells from peripheral blood. In this procedure the human blood is directed through a particular machine that separates key or necessary components through filtration process or centrifuge process and the remaining or not required components are re-infused in the human/ patient body. The whole task requires around two hours of time and it is a safe and painless medical procedure.
Based on product type, the global market can be segmented as devices and disposable & reagents. Among these, disposable & reagents held the largest share in 2020 and is expected to show a high growth during the forecast period. Need of fresh reagents and disposables for each procedure is a key factor driving growth of this segment market. Rising application area of apheresis is another factor supporting the growth of this segment market.
On the basis of method, the global market can be segmented as centrifugation, membrane separation, and selective adsorption. The centrifugation method has accounted for the largest share in 2020 and will continue to hold its market position throughout the forecast period.
High applications of centrifugation method in various apheresis procedures such as in the preparation of fresh frozen plasma and packed RBCs. However, the membrane separation is expected to register the highest growth during the forecast period.
On the basis of procedure, the global market can be segmented as donor/automated apheresis and therapeutic apheresis. The therapeutic apheresis segment has accounted for the largest share in the apheresis market in 2020 and will continue to hold its market position throughout the forecast period. This is owing to rising preference for therapeutic apheresis in the treatment of renal, neurological, and blood associated diseases.
Based on component, the market can be segmented as plasma (plasmapheresis), platelets (plateletpheresis), leukocytes (leukapheresis), lymphocytes (lymph apheresis), photopheresis, and RBC's (erythropheresis). The photopheresis segment projected to witness the fastest growth during the forecast period. Rising prevalence of various blood related disorders and increasing number of organ transplantation procedures across the globe are the key factors driving growth of the photopheresis segment market.
Based on end-user, the market can be segmented as blood centers, hospitals, and other end users. The blood centres segment has accounted the highest share in 2020 and is expected to show observe significant growth trend over the forecast period. Rising blood donation camps, increasing government initiatives for blood donation, and growing trend of blood component donation across the globe are major factors supporting the growth of the apheresis procedure at blood centres across the globe and in turn driving market growth of this segment.
However, hospitals segment has accounted for second leading position in terms of market share.
On the basis of region, the global apheresis market can be segmented as North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The North America region dominated the global apheresis market in 2020 and is expected to maintain its dominance over the forecast period. This is owing to the presence of advanced blood collection facilities, strong presence of blood collection centres, high product penetration, and high awareness among individuals about blood component donation.
However, Asia Pacific region is expected to register the highest growth during the forecast period. Rising end user base, growing population, and increasing prevalence of blood disorders are some of the major factors driving the growth of the Asia Pacific region market.
The COVID-19 outbreak has made a positive impact on apheresis market. In the critical stage of COVID-19 the plasma blood treatment proves an effective and lifesaving treatment for the patients which is the major driving factor for the growth of the apheresis market during this pandemic. Furthermore, government is supporting blood plasma treatment during this pandemic. As the demand of blood plasma therapy is increasing among the COVID- 19 patients, the positive impact observed on the market.
|1||The apheresis market is witnessing a rising trend of blood component donation among individuals across the globe and is further expected drive the growth of market over the forecast period.||Positive|
|2||Rising number of stem cell banks and growing blood collection centres are some of the other trends witnessed in the global market.||Positive|
Ask for free product review call with the author
Share your specific research requirements for a customized report
Request for due diligence and consumer centric studies
Request for study updates, segment specific and country level reports